Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2012

View Archived Issues

Polymorphism improves recovery after HBV infection

Studies show utility of florbenazine F18 in Parkinson's disease settings

Researchers at Piramal Life Sciences prepare new PI3Kalpha inhibitors

Siena Biotech patents new SMO receptor antagonists

Novel FPR2/ALX receptor agonists divulged by Actelion Pharmaceuticals

New myostatin-targeted antibody shows promise to treat cancer

New candidate cancer therapeutics designed at CSIR

Novel recombinant protein product prevents muscle damage in muscular dystrophy model

Boehringer Ingelheim presents novel MPGES-1 inhibitors

Phase I trial assesses ASG-5ME in castration-resistant prostate cancer

Astellas plans Japanese launch of extended-release tablet for restless legs syndrome

First EMA-approved artemisinin-based combination drug for uncomplicated malaria is available

Application filed in U.S. for Kineret in new indication

Endpoints met in pivotal trial of Vifor phosphate binder

Bayer product enters phase II/III hemophilia A study

New trial testing anti-inflammatory properties of RPL-554

BrainStorm Cell Therapeutics discloses encouraging data on ALS therapy

Tuberculosis partnership launches first screening round for new drug candidates

FDA approves first KRAS companion diagnostic test and Erbitux for new indication

Investigators identify possible new therapeutic target for osteoarthritis

Medigene grants exclusive EndoTAG-1 rights to SynCore

Epistem obtains CE-IVD registration for TB test

Uriach and Hyphens Pharma extend collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...